BLRX BioLineRX Ltd Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

BioLineRX (BLRX) Stock: Buy, Sell, or Hold?

$1.35
-0.14 (-9.40%) β–Ό
5d: -23.64% 30d: -34.94% 90d: -51.09%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
34/100
Position
OVERSOLD
30-Day Fair Range
$1.74 – $2.22
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$22.00
+1529.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.35 / $1.99
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BLRX is down 23.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When BLRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: BLRX is currently trading at $1.35, which is considered oversold relative to its 30-day fair value range of $1.74 to $2.22.

Technical Outlook: Technically, BLRX is in a strong downtrend. The price is currently testing key support at $1.35. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.4% recently.

Market Sentiment: BLRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.00 (+1529.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.74 - $2.22
Company Quality Score 34/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $1.74 - $2.22
Current vs Trading Range OVERSOLD
Support Level $1.35
Resistance Level $1.99
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-9.4%)
  • BULLISH: Trading 1529.6% below Wall St target ($22.00)
  • WARNING: Composite score 34/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.54
Wall Street Target $22.00 (+1529.6%)
Revenue Growth (YoY) -3.3%
Share BLRX Analysis

Share this live BLRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (BLRX)

Bullish 1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Aug 19, 2022
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on BLRX are bullish (sentiment score +0.38) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BLRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 53 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 52 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 50 HOLD
RAPP
Rapport Therapeutics, In…
STRONG BUY
16 analysts
$64 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive BLRX Research Pages
BLRX Technical Chart BLRX Price Prediction BLRX Intrinsic Value DCF BLRX Earnings Date BLRX Investment Advisor BLRX Fair Price Analyzer BLRX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals